Oral transgene vaccination mediated by attenuated Salmonellae is an effective method to prevent Herpes simplex virus-2 induced disease in mice.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Vaccine

• Publication date

  2001-02-08

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0264-410X(00)00375-3PMID 11166903
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Molecular Cloning: A Laboratory Manual

  2001cited by this paper
• Herpes simplex virus vaccines.

  1999cited by this paper
• Immunization against genital herpes with a vaccine virus that has defects in productive and latent infection.

  1999cited by this paper
• Live attenuated Salmonella: a paradigm of mucosal vaccines

  1999cited by this paper
• The role of gamma interferon in immune resistance to vaginal infection by herpes simplex virus type 2 in mice.

  1999cited by this paper
• Mucosal DNA vaccine immunization against measles with a highly attenuated Shigella flexneri vector.

  1999cited by this paper
• Role of mucosal immunity in herpes simplex virus infection.

  1998cited by this paper
• Mucosal Immunity to Herpes Simplex Virus Type 2 Infection in the Mouse Vagina Is Impaired by In Vivo Depletion of T Lymphocytes

  1998cited by this paper
• Priming or tolerization of the B- and Th2-dependent immune response by the oral administration of OVA-DNP is determined by the antigen dosage.

  1998cited by this paper
• Monoclonal Antibodies to Distinct Sites on Herpes Simplex Virus (HSV) Glycoprotein D Block HSV Binding to HVEM

  1998cited by this paper
• Gene transfer in dendritic cells, induced by oral DNA vaccination with Salmonella typhimurium, results in protective immunity against a murine fibrosarcoma.

  1998cited by this paper
• T lymphocytes are required for protection of the vaginal mucosae and sensory ganglia of immune mice against reinfection with herpes simplex virus type 2.

  1998cited by this paper
• Induction of mucosal immunity against herpes simplex virus by plasmid DNA immunization

  1997cited by this paper
• Potency testing of tissue culture rinderpest vaccine in rabbits.

  1997cited by this paper
• Interferon-gamma enhances resolution of herpes simplex virus type 2 infection of the murine genital tract.

  1997cited by this paper
• Oral somatic transgene vaccination using attenuated S. typhimurium.

  1997cited by this paper
• The prophylactic effect of immunization with DNA encoding herpes simplex virus glycoproteins on HSV-induced disease in guinea pigs.

  1997cited by this paper
• A Salmonella typhimurium htrA live vaccine expressing multiple copies of a peptide comprising amino acids 8–23 of herpes simplex virus glycoprotein D as a genetic fusion to tetanus toxin fragment C protects mice from herpes simplex virus infection

  1996cited by this paper
• Immunization with DNA vaccines encoding glycoprotein D or glycoprotein B, alone or in combination, induces protective immunity in animal models of herpes simplex virus-2 disease.

  1996cited by this paper
• DNA immunization against experimental genital herpes simplex virus infection.

  1996cited by this paper
• DNA immunization confers protective immunity on mice challenged intravaginally with herpes simplex virus type 2.

  1996cited by this paper
• Analysis of herpes simplex virus-specific T cells in the murine female genital tract following genital infection with herpes simplex virus type 2.

  1995cited by this paper
• Attenuated Shigella as a DNA Delivery Vehicle for DNA-Mediated Immunization

  1995cited by this paper
• Characterization of herpes simplex virus type-1 infection and herpetic stromal keratitis development in IFN-gamma knockout mice.

  1995cited by this paper
• Control of acute cutaneous herpes simplex virus infection : T cell-mediated viral clearance is dependent upon interferon-γ (IFN-γ)

  1994cited by this paper
• A mouse model for studies of mucosal immunity to vaginal infection by herpes simplex virus type 2.

  1994cited by this paper
• Control of acute cutaneous herpes simplex virus infection: T cell-mediated viral clearance is dependent upon interferon-gamma (IFN-gamma).

  1994cited by this paper
• Macrophages and other nonspecific defenses: role in modulating resistance against herpes simplex virus.

  1992cited by this paper
• Vaccines : new approaches to immunological problems

  1992cited by this paper
• Introduction: objectives of herpes simplex virus vaccines seen from a historical perspective.

  1991cited by this paper
• Specific effect of interferon on the herpes simplex virus type 1 transactivation event

  1990cited by this paper
• T lymphocytes in genital lymph nodes protect mice from intravaginal infection with herpes simplex virus type 2.

  1989cited by this paper
• Localization and synthesis of an antigenic determinant of herpes simplex virus glycoprotein D that stimulates the production of neutralizing antibody

  1984cited by this paper
• Genital herpesvirus hominis infection in mice. I. Development of an experimental model

  1975cited by this paper

• Approved natural products-derived nanomedicines for disease treatment.

  2024cites this paper
• Oral Vaccination with a DNA Vaccine Encoding Capsid Protein of Duck Tembusu Virus Induces Protection Immunity

  2018cites this paper
• Microneedle‐Mediated Vaccine Delivery to the Oral Mucosa

  2018cites this paper
• Attenuated Salmonella Typhimurium delivery of a novel DNA vaccine induces immune responses and provides protection against duck enteritis virus.

  2016cites this paper
• Konstrukcja szczepionek podjednostkowych z wykorzystaniem komórek Salmonella enterica jako nośnika heterologicznych genów

  2013cites this paper
• Salmonella enterica as a vaccine carrier.

  2012cites this paper
• Attenuated Salmonella enteritidis E23 as a vehicle for the rectal delivery of DNA vaccine coding for HIV‐1 polyepitope CTL immunogen

  2012cites this paper
• DNA Vaccines

  2012cites this paper
• DNA Vaccines for Infectious Diesase

  2011cites this paper
• Oral and intranasal administration of somatostatin DNA vaccine mediated by attenuated Salmonella enterica serovar Typhimurium to promote growth of piglets.

  2011cites this paper
• Parasites or Cohabitants: Cruel Omnipresent Usurpers or Creative “Éminences Grises”?

  2011cites this paper
• Activation and Genetic Modification of Human Monocyte-Derived Dendritic Cells using Attenuated Salmonella typhimurium

  2010cites this paper
• Bacterial Antigen Expression Is an Important Component in Inducing an Immune Response to Orally Administered Salmonella-Delivered DNA Vaccines

  2009influential citation
• Comparative analysis of the immunogenicity of SARS-CoV nucleocapsid DNA vaccine administrated with different routes in mouse model

  2009cites this paper
• Intragastric administration of attenuated Salmonella typhimurium harbouring transmissible gastroenteritis virus (TGEV) DNA vaccine induced specific antibody production

  2009cites this paper
• The development of gene therapy: from monogenic recessive disorders to complex diseases such as cancer.

  2009cites this paper
• Salmonella enterica serovar Typhi live vector vaccines finally come of age

  2009cites this paper
• Bacterial Vector in Gene Therapy

  2008cites this paper
• Genetic immunization: Bacteria as DNA vaccine delivery vehicles

  2008cites this paper
• Engineering of cytomegalovirus genomes for recombinant live herpesvirus vaccines.

  2008cites this paper
• Impact of prior immunological exposure on vaccine delivery by Salmonella enterica serovar Typhimurium.

  2008cites this paper
• Tolerance in the absence of autoantigen.

  2007cites this paper
• Induction of Specific Immune Responses by Severe Acute Respiratory Syndrome Coronavirus Spike DNA Vaccine with or without Interleukin-2 Immunization Using Different Vaccination Routes in Mice

  2007cites this paper
• Optimization of an FaeG DNA vaccine in pigs

  2007cites this paper
• Systemic and mucosal immunity induced by oral somatic transgene vaccination against glycoprotein B of pseudorabies virus using live attenuated Salmonella typhimurium.

  2006cites this paper
• Vaccination strategies for the prevention of swine dysentery

  2006cites this paper
• Bacterial gene therapy strategies

  2006cites this paper
• Attenuated Salmonella typhimurium reduces ovalbumin‐induced airway inflammation and T‐helper type 2 responses in mice

  2006cites this paper
• Glycoprotein D adjuvant herpes simplex virus vaccine

  2005cites this paper
• Focus on Increasing Potency and Efficacy

  2005cites this paper
• Chapter 56 – Antigen Delivery Systems II: Development of Live Recombinant Attenuated Bacterial Antigen and DNA Vaccine Delivery Vector Vaccines

  2005cites this paper
• Mucosal immunity

  2004cites this paper
• Bacteria in the treatment of cancer.

  2004cites this paper
• Bacteria as DNA vaccine carriers for genetic immunization.

  2004cites this paper
• Humoral immune response induced by oral administration of S. typhimurium containing a DNA vaccine against porcine reproductive and respiratory syndrome virus.

  2004cites this paper
• Bacteria-mediated DNA transfer in gene therapy and vaccination

  2004cites this paper
• Co-immunization with plasmids coding the full length and a soluble form of glycoprotein D of HSV-2 induces protective cellular and humoral immune response in mice.

  2003cites this paper
• Advances in oral vaccine delivery options

  2003cites this paper
• Animal models paving the way for clinical trials of attenuated Salmonella enterica serovar Typhi live oral vaccines and live vectors.

  2003cites this paper
• Live attenuated bacteria as vectors to deliver plasmid DNA vaccines.

  2003cites this paper
• Recent Progress in Herpes Simplex Virus Immunobiology and Vaccine Research

  2003cites this paper
• Attenuated Salmonella and Shigella as Carriers for DNA Vaccines

  2003influential citation
• Transfer of eukaryotic expression plasmids to mammalian hosts by attenuated Salmonella spp.

  2003cites this paper
• Modulation of the immune response mediated by oral transgene administration of IL-10.

  2002cites this paper
• Development of an oral prime-boost strategy to elicit broadly neutralizing antibodies against HIV-1.

  2002cites this paper
• Salmonella vaccines for use in humans: present and future perspectives.

  2002cites this paper
• Lawrence Corey Immunobiology and Vaccine Research Recent Progress in Herpes Simplex Virus

  2002cites this paper
• Transfer of eukaryotic expression plasmids to mammalian host cells by bacterial carriers.

  2001cites this paper